Corroborating the cardiac findings, in a model of nonalcoholic steatohepatitis, IL-11 inhibition by X203 or X209 decreased liver fibrosis by suppressing ERK activation and consequently MMP2 and TIMP1 [35]. Here, IL11 is linked to metabolic dysfunction-associated steatohepatitis.